Nearly 15 percent of U.S. adults continue to smoke, often because long-term health risks feel too abstract compared with the immediate rewards. Jeff Stein, an addiction researcher at Virginia Tech’s Fralin Biomedical Research Institute, is leading a National Cancer Institute–funded study testing whether episodic future thinking — a strategy that helps people vividly imagine their personal future — can reduce impulsivity and support quitting. The fully remote study will enroll 128 participants nationwide and combine the intervention with counseling and nicotine patches.

Deep learning model trained with stage II colorectal cancer whole slide images identifies features associated with risk of recurrence – with higher success rate than clinical prognostic parameters

Large language models (LLM) can generate treatment recommendations for straightforward cases of hepatocellular carcinoma (HCC) that align with clinical guidelines but fall short in more complex cases, according to a new study by Ji Won Han from The Catholic University of Korea and colleagues publishing January 13^th in the open-access journal PLOS Medicine.

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, the novel monoclonal antibody linavonkibart demonstrated the potential to overcome treatment resistance to anti-PD-1 immune checkpoint inhibitors in multiple cancer types.

BUFFALO, NY – January 13, 2026 – A new hypothesis article was published in Oncotarget (Volume 17) on January 3, 2026, titled “Hypothesis: HPV E6 and COVID spike proteins cooperate in targeting tumor suppression by p53.”